U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT04780061) titled 'Dietary Supplements for COVID-19' on March 1.
Brief Summary: This is a double blind, placebo controlled, phase III randomized controlled trial evaluating the effects of the dietary supplements vitamin C, vitamin D, vitamin K, and zinc versus placebo on the overall health, symptom severity, and symptom duration of outpatients diagnosed with SARS-CoV-2.
Study Type: Interventional
Condition: Covid19
Intervention: * Drug: Vitamin D3 50,000 IU
This is a loading dose of Vitamin D. Vitamin D (cholecalciferol [vitamin D3]) is a fat-soluble vitamin that is synthesized following ultraviolet radiation to the skin, naturally occurs in a few...